HIV, HBV AND HCV VIRUS NUCLEIC ACID - ANVISA Registration 80134860319

Access comprehensive regulatory information for HIV, HBV AND HCV VIRUS NUCLEIC ACID in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80134860319 and manufactured by GRIFOLS DIAGNOSTIC SOLUTIONS INC.. The registration is held by GRIFOLS BRASIL LTDA with validity until Jul 28, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 4 companies making the same product including GRIFOLS DIAGNOSTIC SOLUTIONS INC., ROCHE MOLECULAR SYSTEMS, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.